Back to Search
Start Over
Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators
- Source :
- EJSO-European Journal of Surgical Oncology, EJSO-European Journal of Surgical Oncology, WB Saunders, 2020, 47 (2), pp.360-366. ⟨10.1016/j.ejso.2020.08.003⟩, EJSO-European Journal of Surgical Oncology, 2020, 47 (2), pp.360-366. ⟨10.1016/j.ejso.2020.08.003⟩
- Publication Year :
- 2020
- Publisher :
- HAL CCSD, 2020.
-
Abstract
- International audience; Objectives: In 2016, the European Society of Gynecology Oncology (ESGO) published indicators defining the quality of surgical management of advanced ovarian cancer. The objective of the study was to assess the quality of ovarian cancer patient management in regional centers authorized for gynecological cancer, based on the ESGO list of quality indicators. Methods: A multicenter retrospective observational cohort study was conducted from January 1 to June 30, 2016. The following quality indicators 1 "rate of complete surgical resection", 4 "center participating in clinical trials in gynecologic oncology", 5 "treatment planned and reviewed at a multidisciplinary team meeting", 6 "required preoperative workup", 8 "minimum required elements in operative reports" and 9 "minimum required elements in pathology reports" were selected. Results: 91 patients were evaluated in 16 centers. The required preoperative workup was incomplete in 25% of cases. Treatment was not planned at a multidisciplinary team meeting for 24%. An evaluation score of peritoneal involvement was included in 40% of the operative reports and the quality of surgical resection was reported in 72%. Primary surgery was most often performed in a peripheral hospital (48%), interval surgery in a private center (37%), and closure surgery in a regional cancer center (43%). No institution respected the six quality indicators evaluated. One regional cancer center respected five items and two private centers did not respect any. Conclusion: Whilst the ESGO quality indicators provide objective, validated and evaluable support which centers can use to improve quality of care, we observed heterogeneous practices amongst the centers evaluated.
- Subjects :
- medicine.medical_specialty
Quality Assurance, Health Care
media_common.quotation_subject
[SDV.CAN]Life Sciences [q-bio]/Cancer
Gynecologic oncology
03 medical and health sciences
Gynecologic Surgical Procedures
0302 clinical medicine
[SDV.CAN] Life Sciences [q-bio]/Cancer
Ovarian cancer
Operative report
Humans
Medicine
Quality (business)
Quality Indicators, Health Care
Retrospective Studies
media_common
Ovarian Neoplasms
Advanced ovarian cancer
030219 obstetrics & reproductive medicine
business.industry
General Medicine
Middle Aged
medicine.disease
Quality assurance
3. Good health
Surgery
Clinical trial
Oncology
030220 oncology & carcinogenesis
Female
France
Quality of treatment
business
Follow-Up Studies
Cohort study
Subjects
Details
- Language :
- English
- ISSN :
- 07487983
- Database :
- OpenAIRE
- Journal :
- EJSO-European Journal of Surgical Oncology, EJSO-European Journal of Surgical Oncology, WB Saunders, 2020, 47 (2), pp.360-366. ⟨10.1016/j.ejso.2020.08.003⟩, EJSO-European Journal of Surgical Oncology, 2020, 47 (2), pp.360-366. ⟨10.1016/j.ejso.2020.08.003⟩
- Accession number :
- edsair.doi.dedup.....31251b425160e37c129bd7cf3e1d9bfe
- Full Text :
- https://doi.org/10.1016/j.ejso.2020.08.003⟩